Merck KGaA announces new results for bifunctional immunotherapy M7824
admin 22nd October 2018 Uncategorised 0Includes data for head and neck cancer, biliary tract cancer and esophageal cancers
More: Merck KGaA announces new results for bifunctional immunotherapy M7824
Source: News